Cargando…

Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up

AIMS: Long-term results from catheter ablation therapy for atrial fibrillation (AF) remain uncertain and clinical practice guidelines recommend continuation of long-term oral anticoagulation in patients with a high stroke risk. Left atrial appendage closure (LAAC) with Watchman has emerged as an alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Karen P, Pokushalov, Evgeny, Romanov, Aleksandr, Artemenko, Sergey, Folkeringa, Richard J, Szili-Torok, Tamas, Senatore, Gaetano, Stein, Kenneth M, Razali, Omar, Gordon, Nicole, Boersma, Lucas V A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982721/ https://www.ncbi.nlm.nih.gov/pubmed/29106523 http://dx.doi.org/10.1093/europace/eux183

Ejemplares similares

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
por: Boersma, Lucas V.A., et al.
Publicado: (2016)

Left Atrial Appendage Closure – The WATCHMAN Device
por: Akinapelli, Abhilash, et al.
Publicado: (2015)

The Canadian WATCHMAN Registry for Percutaneous Left Atrial Appendage Closure
por: Saw, Jacqueline, et al.
Publicado: (2023)

Watchman Left Atrial Appendage Closure After Incomplete AtriClip Closure
por: Ice, Daniel S., et al.
Publicado: (2022)

Percutaneous interventions in elderly patients with atrial fibrillation: left atrial ablation and left atrial appendage occlusion
por: Mikhaylov, Evgeny N, et al.
Publicado: (2017)

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
por: Alipour, Arash, et al.
Publicado: (2017)

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
por: Ke, Jin-Yan, et al.
Publicado: (2022)

Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry
por: Phillips, Karen P., et al.
Publicado: (2019)

Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings
por: Sakriss, Charlotte, et al.
Publicado: (2023)

Recurrent Left Pleural Effusion Following Left Atrial Appendage Closure With the Watchman Device
por: Halaby, Rim, et al.
Publicado: (2020)

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
por: Reddy, Vivek Y., et al.
Publicado: (2016)

Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience
por: Phillips, Karen P., et al.
Publicado: (2016)

Impact of conscious sedation and general anesthesia on periprocedural outcomes in Watchman left atrial appendage closure
por: Kleinecke, Caroline, et al.
Publicado: (2021)

Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure With the WATCHMAN Device
por: Tan, Bryan E-Xin, et al.
Publicado: (2021)

Comparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females
por: Alhuarrat, Majd Al Deen, et al.
Publicado: (2023)

Comparison of intracardiac vs. transesophageal echocardiography for “one-stop” procedures of combined radiofrequency catheter ablation and left atrial appendage closure with the Watchman device in the treatment of atrial fibrillation
por: Shang, Xining, et al.
Publicado: (2023)

Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2019)

Utilization of WATCHMAN FLX for surgically incomplete left atrial appendage occlusion: a multicentre case series
por: Golzarian, Hafez, et al.
Publicado: (2023)

Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure
por: Fukuda, Nobuyuki, et al.
Publicado: (2022)

Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage
por: Nandar, Phoo Pwint, et al.
Publicado: (2018)

Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
por: Zhai, Zhengqin, et al.
Publicado: (2019)

WATCHMAN FLX implantation with an extremely small left atrial appendage ostium
por: Yano, Masamichi, et al.
Publicado: (2022)

Device-Associated Thrombus with Watchman FLX Left Atrial Appendage Closure Device: A Report of Two Cases
por: Dhaduk, Nehal, et al.
Publicado: (2023)

The Added Value of Preprocedural Cardiac Computed Tomography in Planning Left Atrial Appendage Closure With the Watchman FLX Device
por: Kassab, Joseph, et al.
Publicado: (2023)

Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device
por: Luani, Blerim, et al.
Publicado: (2017)

Small thrombi and incomplete endothelialization detected by cardiac endoscopy after left atrial appendage closure using Watchman device
por: Abe, Ryo, et al.
Publicado: (2020)

Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience
por: Saad, Mohammed, et al.
Publicado: (2021)

A Comparative Study of Three Imaging Modalities for Size Selection of a Watchman Left Atrial Appendage Closure Device
por: Ruan, Zhong-bao, et al.
Publicado: (2022)

Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement
por: Ahuja, Tania, et al.
Publicado: (2019)

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device
por: Luani, Blerim, et al.
Publicado: (2019)

Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center
por: Xue, Xin, et al.
Publicado: (2018)

Left atrial appendage closure with Watchman device: Insights from the first-ever Tunisian experience and six-year follow-up
por: Chamtouri, Ikram, et al.
Publicado: (2021)

Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
por: Prabhakar Bhat, Sangeeta, et al.
Publicado: (2021)

Correction to: Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Effect of Left Atrial Appendage Closure in Combination With Catheter Ablation on Left Atrial Function for Persistent Atrial Fibrillation
por: Yang, Jing, et al.
Publicado: (2021)

Personalized Fluoroscopic Angles in Watchman™ Left Atrial Appendage Closure Landing Zone Assessment: A Three-Dimensional Printed Simulation Study
por: Shee, Vikram, et al.
Publicado: (2020)

Left atrial appendage closure: shutting down the coagulation factory hall
por: Aarnink, Errol W., et al.
Publicado: (2022)

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0rd63m42t05vs6dujhcnfkpdks